We are live on ! Find out more
FG

Fairman Group Portfolio holdings

AUM $117M
1-Year Est. Return 5.24%
This Fund
S&P 500
This Quarter Est. Return
+7.17%
1 Year Est. Return
+5.24%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$122M
AUM Growth
+$12.5M
Cap. Flow
+$2.83M
Cap. Flow %
2.33%
Top 10 Hldgs %
71.27%
Holding
261
New
4
Increased
61
Reduced
27
Closed
4

Sector Composition

Rank Sector Weight
1 Technology 24.5%
2 Financials 11.8%
3 Healthcare 5.27%
4 Consumer Discretionary 1.16%
5 Communication Services 0.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOC icon
226
Healthpeak Properties
DOC
$15.4B
$893 ﹤0.01%
51
OTIS icon
227
Otis Worldwide
OTIS
$27.6B
$792 ﹤0.01%
8
GSK icon
228
GSK
GSK
$103B
$777 ﹤0.01%
20
BIIB icon
229
Biogen
BIIB
$29.9B
$754 ﹤0.01%
6
TAK icon
230
Takeda Pharmaceutical
TAK
$55.1B
$711 ﹤0.01%
45
CMA
231
DELISTED
Comerica
CMA
$664 ﹤0.01%
11
BABA icon
232
Alibaba
BABA
$269B
$577 ﹤0.01%
5
SCHD icon
233
Schwab US Dividend Equity ETF
SCHD
$102B
$573 ﹤0.01%
22
+1
+5% +$26
ABEV icon
234
Ambev
ABEV
$47.3B
$569 ﹤0.01%
234
PUK icon
235
Prudential
PUK
$36.5B
$550 ﹤0.01%
22
THC icon
236
Tenet Healthcare
THC
$20.1B
$528 ﹤0.01%
3
K
237
DELISTED
Kellanova
K
$477 ﹤0.01%
6
SLB icon
238
SLB Ltd
SLB
$78.4B
$477 ﹤0.01%
14
CVS icon
239
CVS Health
CVS
$137B
$345 ﹤0.01%
5
WBD icon
240
Warner Bros
WBD
$64.6B
$275 ﹤0.01%
24
PENN icon
241
PENN Entertainment
PENN
$2.74B
$268 ﹤0.01%
15
HLN icon
242
Haleon
HLN
$43.1B
$259 ﹤0.01%
25
REFR icon
243
Research Frontiers
REFR
$16.1M
$203 ﹤0.01%
125
MAT icon
244
Mattel
MAT
$4.17B
$197 ﹤0.01%
10
JXN icon
245
Jackson Financial
JXN
$8.32B
$178 ﹤0.01%
2
NEUE
246
DELISTED
NeueHealth
NEUE
$173 ﹤0.01%
25
FULT icon
247
Fulton Financial
FULT
$4.7B
$162 ﹤0.01%
9
IMMR icon
248
Immersion
IMMR
$216M
$150 ﹤0.01%
19
GEHC icon
249
GE HealthCare
GEHC
$27.6B
$148 ﹤0.01%
2
OGN icon
250
Organon & Co
OGN
$3.55B
$146 ﹤0.01%
15

Similar funds

Fairman Group's Q2 2025 Portfolio in Review

As of Q2 2025, Fairman Group held 261 positions worth $122M, up 11% from $109M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Trading was light in Q2 2025: portfolio turnover was 3.1%. Fairman Group opened 4 new positions and exited 4, leaving the 261-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.

  • Fairman Group's largest Q2 2025 buy was Rivian: 2,228 shares worth $30.6K.
  • Fairman Group added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $5.91M increase.
  • Fairman Group's biggest Q2 2025 reduction was Veeva Systems, cutting an estimated $1.23M.
  • Fairman Group fully exited Accolade Inc in Q2 2025, selling an estimated $3.88M.
  • Fairman Group's ten largest holdings make up 71% of its $122M portfolio in Q2 2025.
  • Fairman Group opened 4 new positions and closed 4 in Q2 2025.
  • Fairman Group's portfolio value rose 11% quarter-over-quarter to $122M.

Based on Fairman Group's 13F filing for Q2 2025, filed 28 Jul 2025.